Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/14/1996 | US5516808 Antibiotic gel |
05/14/1996 | US5516778 Method for improving tissue antioxidant status |
05/14/1996 | US5516770 Rapamycin formulation for IV injection |
05/14/1996 | US5516761 Pour-on formulations containing polymeric material |
05/14/1996 | US5516537 Frozen comestibles |
05/14/1996 | US5516531 Spherical granules having core and their production |
05/14/1996 | US5516530 High strength; freezing, liquifying, shaping; freeze drying; tablets; high speed disintegration |
05/14/1996 | US5516527 Capsule containing benificial agents surrounded by porouscoating permeable to aqueous medium; fish tanks, soils |
05/14/1996 | US5516526 Compositions containing DMSO and Fructose 1,6-diphosphate |
05/14/1996 | US5516524 Dioctylsulfosuccinate |
05/14/1996 | US5516523 Transmucosal delivery of macromolecular drugs |
05/14/1996 | US5516522 Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same |
05/14/1996 | US5516457 Ultraviolet absorbing compositions |
05/14/1996 | US5516395 Process for the production of collagen foams in the form of continuous tapes and their use in medicine, cosmetics and hygiene |
05/14/1996 | CA2088273C Processes for formulating a solid oral dosage form of loperamide compounds |
05/11/1996 | CA2162520A1 Cosmetic or dermatological compositions as an oily phase dispersed in an aqueous phase stabilized with cubic gel particles and process for producing the same |
05/10/1996 | CA2162342A1 Intravenous solutions for a derivative of staurosporine |
05/10/1996 | CA2162341A1 Pharmaceutical carriers |
05/09/1996 | WO1996013522A1 Complementarily bonded two- and three-dimensional supramolecular structures |
05/09/1996 | WO1996013511A1 Poly-unsaturated carbohydrate derivatives, polymers thereof and their use |
05/09/1996 | WO1996013286A2 Modulation of cell proliferation and wound healing |
05/09/1996 | WO1996013277A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
05/09/1996 | WO1996013273A1 Pharmaceutical compositions |
05/09/1996 | WO1996013271A1 Compositions and methods for human gastrointestinal health |
05/09/1996 | WO1996013254A1 Pharmaceutical composition comprising atovaquone |
05/09/1996 | WO1996013253A1 Biodegradable sustained release preparation for treating periodontitis |
05/09/1996 | WO1996013252A1 Process for preparing solid pharmaceutical dosage forms |
05/09/1996 | WO1996013251A1 Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
05/09/1996 | WO1996013250A1 Compositions for increased bioavailability of orally delivered therapeutic agents |
05/09/1996 | WO1996013249A1 Pharmaceutical compositions |
05/09/1996 | WO1996013248A1 Injection-molded dosage form |
05/09/1996 | WO1996013161A1 Creating an aerosolized formulation of insulin |
05/09/1996 | DE4439858A1 Durch Co-Sprühtrocknung erhältliche Polyol-Zusammensetzung Obtainable by co-spray drying polyol composition |
05/09/1996 | DE4439575A1 Pharmaceutical and cosmetic gels, emulsions, creams and films |
05/09/1996 | DE19541333A1 Base coating for solid enteric-coated pharmaceutical |
05/09/1996 | DE19540669A1 Non-parenteral interferon compsn. |
05/09/1996 | DE19539860A1 Oral cyclosporin formulations |
05/09/1996 | CA2203875A1 Complementarily bonded two- and three-dimensional supramolecular structures |
05/09/1996 | CA2203762A1 Compositions and methods for human gastrointestinal health |
05/09/1996 | CA2199847A1 Poly-unsaturated carbohydrate derivatives, polymers thereof and their use |
05/08/1996 | EP0710491A1 Subdermally implantable device |
05/08/1996 | EP0710478A1 Composition for topical application containing a lipase and an active agent precursor |
05/08/1996 | EP0710261A1 Biodegradable particles |
05/08/1996 | EP0710226A1 Novel organic products containing reactive thiol functions, one method for preparing same, and biomaterials containing said products |
05/08/1996 | EP0710122A1 Stabilized pharmaceutical peptide compositions |
05/08/1996 | EP0710117A1 Phosphazene polyelectrolytes as immunoadjuvants |
05/08/1996 | EP0710113A1 Preparation for improving the blood supply containing hard magnetic particles |
05/08/1996 | EP0710108A1 Liquid pharmaceutical composition for oral use containing 2-(4-isobutylphenyl)propionic acid |
05/08/1996 | EP0710104A1 Pharmaceutical compositions for hardly soluble active substances |
05/08/1996 | EP0710103A1 Pharmaceutical compositions for hardly soluble active substances |
05/08/1996 | EP0710102A1 Stabilization of aerosolized proteins |
05/08/1996 | EP0710101A1 Improved method for manufacturing freeze dried dosages in a multilaminate blister pack |
05/08/1996 | EP0651634B1 Cross-linked polyhydroxylic material for enzymatically controlled drug release |
05/08/1996 | EP0580648B1 Process for conditioning of water-soluble substances |
05/08/1996 | EP0514506B1 Lipid formulation system |
05/08/1996 | EP0489119B1 Resuspendable coated magnetic particles and stable magnetic particle suspensions |
05/08/1996 | CN2226462Y Disposable urethral catheterization bag |
05/08/1996 | CN1122109A Veterinary composition containing a proton pump inhibitor |
05/08/1996 | CN1122103A Coated pharmaceutical compositions |
05/08/1996 | CN1121956A Process for preparation of syngnathus tonic wine and oral liquid |
05/08/1996 | CN1121830A Chinese medicine powder capsule for eliminating numbness and preparing method thereof |
05/08/1996 | CN1121826A "Fukangling" medicine for treatment of gynecopathy |
05/08/1996 | CN1121824A Sarcandra glabra chewing-gum and its producing method |
05/08/1996 | CN1121823A Method for producing medicine for treatment of chronic osteomyelitis |
05/08/1996 | CN1121822A "Shenguo" buccal tablet for treatment of acute and chronic throat inflammation and its producing process |
05/08/1996 | CN1121810A Compound Chinese medicine preparation for treatment of osteoporosis and preparing process thereof |
05/08/1996 | CN1121807A "Ailing" anticancer injection |
05/08/1996 | CN1121780A Refreshing chewing-gum |
05/08/1996 | CN1121779A Beauty chewing-gum |
05/08/1996 | CN1121778A Brain tonic chewing-gum |
05/08/1996 | CN1031744C Method for preparing magnetic osmosis medical ointment |
05/07/1996 | US5514720 Stable emulsions of highly fluorinated organic compounds |
05/07/1996 | US5514698 Antifungal vaginal cream composition |
05/07/1996 | US5514673 Pharmaceutical composition containing lipophilic drugs |
05/07/1996 | US5514670 Submicron emulsions for delivery of peptides |
05/07/1996 | US5514663 Laxitive |
05/07/1996 | US5514661 Autoimmune disease treatment |
05/07/1996 | US5514657 Wound healing, silver sulfadiazine, collagen |
05/07/1996 | US5514647 Fibronectin-containing ophthalmic solution, method of preserving an opthalmic solution, and methods of treatment of opthalmic wounds |
05/07/1996 | US5514646 Insulin analogs modified at position 29 of the B chain |
05/07/1996 | US5514384 Wet powder film-forming compositions |
05/07/1996 | US5514383 Process for the preparation of tablets of derivatives of cephalosporanic acid by direct compression |
05/07/1996 | US5514380 Reaction of ethylene oxide polymers with lactides, glycolide and caprolactone |
05/07/1996 | US5514379 Polyoxyalkylene glycol diacid derivative crosslinking agents |
05/07/1996 | US5514377 In situ dissolution of alginate coatings of biological tissue transplants |
05/07/1996 | US5514370 High dosage topical forms of collagenase |
05/07/1996 | US5514365 Pharmaceutical compositions comprising calcitonin for intranasal administration |
05/07/1996 | CA2071488C Base for film-coating pharmaceuticals and method for preparing same |
05/07/1996 | CA2025317C Thrombolytic composition containing tissue type plasminogen activator or derivative thereof |
05/07/1996 | CA2014157C Antiparasitic formulation containing 25-cyclohexyl-avermectin b1 |
05/07/1996 | CA2000283C Proteinaceous composition |
05/05/1996 | CA2161752A1 Delivery of controlled-release system(s) |
05/02/1996 | WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
05/02/1996 | WO1996012733A1 Major outer membrane protein cd of moraxella |
05/02/1996 | WO1996012506A1 Senescent cell-derived inhibitors of dna synthesis |
05/02/1996 | WO1996012504A1 Oil-in-water formulation for topical application |
05/02/1996 | WO1996012495A1 Percutaneously administrable preparation |
05/02/1996 | WO1996012478A1 A controlled release nifedipine delivery device |
05/02/1996 | WO1996012477A1 Controlled release oral delivery system containing oxybutynin |
05/02/1996 | WO1996012476A1 Wet granulation formulation for a piperazinylcamphorsulfonyl oxytocin receptor antagonist |